Penumbra Inc (PEN): Cost of Revenue
$461.23M
Year ended 2025-12-31
$483.98M
Trailing 12 months to 2026-06-30
+13.9%
3-year compound annual growth
+15.7%
5-year compound annual growth
+22.2%
10-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $461.23M | +4.9% | 2026-02-25, From 2025-01-01 |
| 2024-12-31 | $439.62M | +17.0% | 2026-02-25, From 2024-01-01 |
| 2023-12-31 | $375.88M | +20.5% | 2026-02-25, From 2023-01-01 |
| 2022-12-31 | $311.93M | +14.6% | 2025-02-18, From 2022-01-01 |
| 2021-12-31 | $272.21M | +22.5% | 2024-02-22, From 2021-01-01 |
| 2020-12-31 | $222.24M | +26.7% | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | $175.44M | +15.1% | 2022-02-22, From 2019-01-01 |
| 2018-12-31 | $152.41M | +30.7% | 2021-02-23, From 2018-01-01 |
| 2017-12-31 | $116.62M | +26.1% | 2020-02-26, From 2017-01-01 |
| 2016-12-31 | $92.49M | +49.1% | 2019-02-26, From 2016-01-01 |
| 2015-12-31 | $62.04M | +45.4% | 2018-02-27, From 2015-01-01 |
| 2014-12-31 | $42.67M | +37.8% | 2017-02-28, From 2014-01-01 |
| 2013-12-31 | $30.97M | n/a | 2016-03-08, From 2013-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| Penumbra Inc (PEN) | 2025-12-31 | $461.23M | +4.9% |
| Haemonetics Corp (HAE) | 2026-03-28 | $546.44M | -10.7% |
| Merit Medical Systems Inc (MMSI) | 2025-12-31 | $777.64M | +9.0% |
| Integra Lifesciences Holdings Corp (IART) | 2025-12-31 | $803.62M | +10.3% |
| Embecta Corp. (EMBC) | 2025-09-30 | $403.60M | +4.0% |
| Tandem Diabetes Care Inc (TNDM) | 2025-12-31 | $468.72M | +4.0% |
| Teleflex Inc (TFX) | 2025-12-31 | $871.96M | +31.7% |
| Inspire Medical Systems, Inc. (INSP) | 2025-12-31 | $133.22M | +8.3% |
| ICU Medical Inc (ICUI) | 2025-12-31 | $1.41B | -9.5% |
Compare PEN, HAE, MMSI, IART side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗